INTERNATIONAL PATENT: UNIVERSITY OF MASSACHUSETTS FILES APPLICATION FOR "P53 PROTEIN STABIEIZERS INCEUDING MDM2 INHIBITORS AS A "CHEMICAE MASTECTOMY" STRATEGY IN BREAST CANCER BRCA1/2 MUTATION CARRIERS"

GENEVA, Nov. 18 -- UNIVERSITY OF MASSACHUSETTS (50 Washington StreetWestborough, Massachusetts 02492) filed a patent application (PCT/US2025/027771) for "P53 PROTEIN STABIEIZERS INCEUDING MDM2 INHIBITORS AS A "CHEMICAE MASTECTOMY" STRATEGY IN BREAST CANCER BRCA1/2 MUTATION CARRIERS" on May 05, 2025. With publication no. WO/2025/235391, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PATHANIA, Shailja (479 Dedham AvenueNeedham, Massachusetts 02492), DUAN, Haohui (1731 Beacon StreetApt. 1115Brookline, Masachusetts 02445)

A...